One of the core missions of the Yellow4FLAVI consortium is to ensure that its science reaches beyond the laboratory — into the hands of clinicians, researchers, and the scientists of tomorrow. As we r...

🧬 Meet our Partners: Istituto Zooprofilattico Sperimentale Abruzzo e Molise "G. Caporale"​ (IZS-Teramo) 🏫 Continuing our Meet our Partners series, we’re pleased to introduce IZS-Teramo : a...

🔬 Meet our Partners: ImmuneWatch 🏫 This week, Meet our Partners series features ImmuneWatch, a cutting-edge bioinformatics spin-off from the Universiteit Antwerpen and Antwerp University Hospital, i...

Last month, the Ministry of Health (MOH) of Angola officially notified the World Health Organization of the confirmation of seven yellow fever cases.

It’s clear that we’re on the precipice of a surge in preventable diseases. But how bad will it get?

Virologist Amadou Sall is the driving force behind a world-class manufacturing hub in Senegal.

Yellow fever was once mainly sylvatic in remote Colombian regions throughout the 20th century. However, the 21st century has seen the re-emergence of yellow fever in endemic zones and it has spread to...

Rapid transmission through sexual networks raises fears of wider spread in the region

We’d like to shine a spotlight on Dr. Giovanna Barba-Spaeth, Coordinator of the Yellow4FLAVI Horizon Europe funded project and Head of the Flavimmunity Group at Institut Pasteur. 1️⃣ What is your back...

Toward a deeper understanding of dengue: novel method for quantification and isolation of envelope protein epitope-specific antibodies  Sokchea Lay, Candice Bohaud, Sopheak Sorn, Sreymom Ken, Felix A....

Last Wednesday 19th of March LWNVIVAT project held the first seminar in their series on emergent pathogens, with a special focus on flaviviruses. Our Coordinator, Dr. Giovanna Barba-Spaeth led the sem...

Health officials with the State Health Department of the State of São Paulo have reported 20 yellow fever fatalities in the state since December 2024, through February 2025.

Last Wednesday 19th of March LWNVIVAT project held the first seminar in our series on emergent pathogens, with a special focus on flaviviruses.

Yesterday, we held our second online General Assembly, celebrating one year of progress since our kick-off meeting at Institut Pasteur in Paris. The event brought together 42 participants from 11 coun...

Join Us for a Seminar Series on Emerging Pathogens: A [...]

Our project partners at KUM, IP, and LMU have published a new study examining how the state of our immune system before vaccination affects how we respond to the yellow fever 17D (YF17D) vaccine. The ...

A virus originally found in animals, mpox – which causes the disease of the same name – is now circulating in humans. Since 2022, it has been the cause of major epidemics spreading outside endemic are...

Today, we celebrate the incredible women scientists, group leads, postdocs, engineers, PhD students, and research project managers driving Yellow4FLAVI forward! 🚀💡Our project, bringing together 13 Eur...

U.S. public health officials have been told to stop working with the World Health Organization, effective immediately. The surprise decision is focused on the U.S.

Scientific Reports - Enhanced antibody responses in CD19-Cre mice

Happy New Year 2025 from the Yellow4FLAVI Consortium! 🌟 The Yellow4FLAVI team sends its warmest wishes to all our partners, collaborators, scientific…

Yellow4FLAVI Project. Deconstructing the protective immunity of yellow fever virus 17D to inform flavivirus vaccine design.